Leonard S. Schleifer
2012
In 2012, Leonard S. Schleifer earned a total compensation of $30M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 184% increase compared to previous year.
Compensation breakdown
| Bonus | $2,300,000 |
|---|---|
| Option Awards | $26,630,306 |
| Salary | $1,000,000 |
| Other | $116,791 |
| Total | $30,047,097 |
Schleifer received $26.6M in option awards, accounting for 88.63% of the total pay in 2012.
Schleifer also received $2.3M in bonus, $1M in salary and $116.8K in other compensation.
Rankings
In 2012, Leonard S. Schleifer's compensation ranked 37th out of 11,285 executive pay records tracked by us. In other words, Schleifer earned more than 99.7% of all executives tracked by us in 2012.
| Classification | Ranking | Percentile |
|---|---|---|
All | 37 out of 11,285 | 100th |
Manufacturing Division | 16 out of 4,153 | 100th |
Chemicals And Allied Products Major group | 3 out of 1,141 | 100th |
Drugs Industry group | 3 out of 879 | 100th |
Pharmaceutical Preparations Industry | 2 out of 663 | 100th |
Source: SEC filing on April 21, 2015.
Schleifer's colleagues
We found four more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2012.
2012
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2012
Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
2012
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
2012
Robert Terifay
Regeneron Pharmaceuticals